Marijuana a cure for Alzheimer's disease

Scientists do not presently recognise what causes alzheimer's -- a leading nugatory cause of dementia amongst the elderly marked by tenacious memory loss, impaired decision-making, scaled down ductile language accomplishments and hampered reactionary motion -- but it is believed to be hereditary.

presently, marijuana is illegal in most countries, including the cohesive states, but it is lawful in a heap of countries and states for medicinal use to assist relieve the side acoustical effects caused by cancer and auxiliary aids treatments, and to treat glaucoma. " past experiments of the acoustical effects of thc on humane dazed brain tissues and on rats have shown it may reduce inflammation and prevent mental decline, but other studies have shown that heavy marijuana use -- four or more cigarettes a week -- impairs tenacious memory, the capacity to focus, and decision making over the hurrying years. The researchers found that the active ingredient in marijuana -- delta-9-tetrahydrocannabinol, or thc -- is responsible for the positive narcotic effect, as it may prevent the breakdown of the neurotransmitter acetylcholine even better than commercially marketed prescription drugs. "we're not advocating smoking dope, but whether or not we may make analogues of thc, it could play a role in treating alzheimer's," said researcher kim janda, a chemist at scripps. A study conducted by scientists at scripps ponderous exploration institute in california has found that, opposite to marijuana's tarnished character, the ingredients of the drug may in truth fight off the tenacious memory-impairing acoustical effects of alzheimer's disease.

"it would be nice to do more animal studies along these lines. The study similarly showed that thc could totally prevent the enzyme acetylcholinesterase (pain) from forming amyloid plaques, whereas twice as much donepezil and tacrine -- the two drugs approved for alzheimer's lucid treatment -- only scaled down such clumping by 22 and 7 percent, respectively, the researchers reported in the diary molecular pharmaceutics. This led the scientists to conclude that a more efficient alzheimer's drug could be created in the future.